Our mission is to empower the pharmaceutical and healthcare industries by equipping them with advanced Al-driven data analysis tools. We are dedicated to being a part of a healthier future, where precision medicine and accelerated drug discovery lead to better patient outcomes.
At Copoly.ai, we are privileged to be led by a diverse team of visionary leaders, each bringing a wealth of experience and expertise to the forefront of AI-driven biopharmaceutical research
With a Ph.D. in Experimental Medicine and more than 16 years in data analytics and development, Dr. Peng Zhang stands at the forefront of healthcare innovation. His enthusiasm for melding data-driven strategies with transformative healthcare technologies guides Copoly.ai's mission. His diverse expertise fosters an environment where strategic foresight and innovative spirit enrich the biopharma industry.
Dr. Piru Perampalam, who has a Ph.D. in Biochemistry, brings over a decade of expertise in bioinformatics and computational biology to the table. His pivotal role in formulating Copoly.ai's scientific direction embodies a state-of-the-art approach. With extensive experience in optimizing pre-clinical models and applying sophisticated analytical methods, he is dedicated to advancing precision medicine and AI-powered drug discovery platforms.
Giselle Bagatini, with her Master’s in Data Science and over eight years of experience in the field, leads the AI initiatives at Copoly.ai. Her substantial expertise in data science and machine learning drives innovation across diverse industries. Her skill in natural language processing and generative AI is crucial to our projects' success, steering strategic decisions and the implementation of comprehensive data science solutions.
